Skip to main navigation
Instil Bio logo
  • Home
  • News & Events
    • News Releases
    • Events
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Proxy Materials
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • SEC Filings
  • IR Resources
    • FAQs
    • Email Alerts
    • Contact IR

News Releases

May 11, 2023
Instil Bio Reports First Quarter 2023 Financial Results and Provides Corporate Update
March 31, 2023
Instil Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
January 31, 2023
Instil Bio Announces Extension of Cash Runway Beyond 2026 with the Consolidation of R&D Operations to its Manchester, U.K. Site
January 9, 2023
Instil Bio Announces Resumption of Clinical Trial of CoStAR-TIL Candidate ITIL-306 in Lung, Ovarian, and Renal Cancer

Investor Tools

Instil Bio Instil Bio

Footer Menu

  • About
  • Careers
  • Pipeline
  • Contact Us
  • Publications

Site Social Media Links

  • LinkedIn LinkedIn
  • Twitter Twitter
© 2023 Instil Bio. All Rights Reserved
Privacy Policy Terms of Service Agency Policy